| Literature DB >> 26717866 |
Sandeep Kumar Vashist1, A G Venkatesh2, E Marion Schneider3, Christopher Beaudoin4, Peter B Luppa4, John H T Luong5.
Abstract
This review presents advances in assays for human C-reactive protein (CRP), the most important biomarker of infection and inflammation for a plethora of diseases and pathophysiological conditions. Routine assays in clinical settings are based on analyzers, enzyme-linked immunosorbent assays and lateral flow assays. However, assays encompassing novel sensing schemes, improved chemistry, signal enhancement, lab-on-a-chip, microfluidics and smartphone detection, have emerged in recent years. The incorporation of immune-transducing chips or sensing interfaces with nanomaterials enables multiplexing analysis of CRP with co-existing biomarkers. However, there are still considerable challenges in the development of rapid diagnostics for both pentameric and monomeric CRP forms.Entities:
Keywords: Assays; Bioanalytical advances; Biosensors; C-reactive protein; Diagnostics
Mesh:
Substances:
Year: 2015 PMID: 26717866 DOI: 10.1016/j.biotechadv.2015.12.010
Source DB: PubMed Journal: Biotechnol Adv ISSN: 0734-9750 Impact factor: 14.227